5-MAPDI

5-MAPDI (also known as Indanylmethylaminopropane or IMP) is an entactogenic amphetamine derivative which is structurally related to MDMA as well as to dihydrobenzofuran derivatives such as 5-MAPDB and 6-MAPDB, and has been sold as a designer drug. It has reportedly been sold over grey-market websites since around 2014, although the first definitive identification was not made until September 2016 by a forensic laboratory in Slovenia.[1]

5-MAPDI

Clinical data
ATC code	none
Identifiers
IUPAC name 1-(2,3-Dihydro-1H-inden-5-yl)-N-methylpropan-2-amine
CAS Number	1310153-27-5
PubChem CID	57461970
ChemSpider	26679339
Chemical and physical data
Formula	C13H19N
Molar mass	189.297 g·mol^−1
3D model (JSmol)	Interactive image
SMILES CNC(Cc1ccc2c(c1)CCC2)C
InChI InChI=1S/C13H19N/c1-10(14-2)8-11-6-7-12-4-3-5-13(12)9-11/h6-7,9-10,14H,3-5,8H2,1-2H3 Key:MHBKJTHGGWQKSG-UHFFFAOYSA-N

See also

• IBF5MAP

References

1. European Monitoring Center for Drugs and Drug Addiction – Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA